Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Cancer Research|July 31, 2015
Galectin-Binding O-Glycosylations as Regulators of MalignancyCharles J DimitroffCurrent Opinion in Immunology|December 11, 2012
Leveraging fluorinated glucosamine action to boost antitumor immunityCharles J DimitroffProceedings of the National Academy of Sciences of the United States of America|June 20, 2019
I-branched carbohydrates as emerging effectors of malignant progressionCharles J DimitroffThe Journal of Clinical Investigation|November 12, 2019
Cancer immunotherapy needs to learn how to stick to its gunsAsmi Chakraborty, Charles J DimitroffGlycoconjugate Journal|May 1, 2012
Galectins and their ligands: negative regulators of anti-tumor immunityFiliberto Cedeno-Laurent, Charles J DimitroffClinical Immunology (Orlando, Fla.)|October 25, 2011
Galectin-1 research in T cell immunity: past, present and futureFiliberto Cedeno-Laurent, Charles J DimitroffBlood|October 24, 2002
Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skinCharles J Dimitroff, Ralph J Bernacki, Robert SacksteinJournal of Visualized Experiments : Jove|February 21, 2009
Analysis of physiologic E-selectin-mediated leukocyte rolling on microvascular endotheliumGeorg Wiese, Steven R Barthel, Charles J DimitroffThe Journal of Clinical Investigation|October 3, 2003
Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigenCharles J Dimitroff, Thomas S Kupper, Robert SacksteinThe Journal of Investigative Dermatology|May 13, 2006
Ameliorating skin-homing receptors on malignant T cells with a fluorosugar analog of N-acetylglucosamine: P-selectin ligand is a more sensitive target than E-selectin ligandLeyla Descheny, Madeliene E Gainers, Bruce Walcheck, et al.Pageof 5